Stay updated on Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov site frame instead of the 403 error, with the revision label updated to v3.7.2; the study content area appears blank.
    Difference
    0.6%
    Check dated 2026-10-17T22:24:29.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1; the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:16:15.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    There are no additions or deletions in the provided changes. The page context shows a 403 Forbidden error, indicating restricted access.
    Difference
    0.2%
    Check dated 2026-09-26T22:01:42.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the expected study record content and preventing access to the study details.
    Difference
    19%
    Check dated 2026-09-19T20:36:17.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6. This reflects a small internal update to the page’s content or metadata without altering study information.
    Difference
    0.1%
    Check dated 2026-08-29T19:35:48.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The web page shows a new revision version, updating from v3.6.4 to v3.6.5. This indicates a minor platform or content management update rather than a change to the study details presented on the page.
    Difference
    0.1%
    Check dated 2026-08-08T23:13:13.000Z thumbnail image

Stay in the know with updates to Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page.